Echo Therapeutics, Inc. announced that the company rehired key members of its Research & Development team to support the implementation of a new corporate strategy. Effective December 31, 2014, as required by the investors in the announced financing, Vincent Enright, William Grieco and James Smith resigned from the company's Board of Directors.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+8.88% | 221B | |
+8.68% | 186B | |
+14.25% | 137B | |
+28.18% | 109B | |
+14.65% | 52.68B | |
+4.48% | 50.86B | |
+4.39% | 42.53B | |
+7.00% | 37.76B | |
+26.06% | 31.86B |